United States· US:51167-290_680dd873-8717-41be-a143-2fc36acf07ea
CASGEVY
A exagamglogene autotemcel product containing exagamglogene autotemcel, registered in United States by Vertex Pharmaceuticals Incorporated. The same ATC class is registered in 12 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Exagamglogene autotemcel is registered in 12 of 19 countries.
Countries holding a registration under ATC B06AX05 (exagamglogene autotemcel), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 8 of them publish a price we can compare per daily dose
Exagamglogene autotemcel · ATC B06AX05
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- EXAGAMGLOGENE AUTOTEMCEL
- Manufacturer
- Vertex Pharmaceuticals Incorporated
- Country
- United States (US)
- ATC code
- B06AX05
- ATC class
- Exagamglogene autotemcel
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc1151167-290-09
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Exagamglogene autotemcel in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumCasgevy 4 10*6 cells/ml - 13 10*6 cells/mlVertex Pharmaceuticals (Ireland)
- SwitzerlandCasgevy 4-13 x 10e6 cells/ml, InfusionsdispersionVertex Pharmaceuticals (CH) GmbH
- CzechiaCASGEVYVertex Pharmaceuticals (Ireland) Limited, Dublin
- SpainCASGEVY 4 - 13 × 10E6 CELULAS/ML DISPERSION PARA PERFUSIONVertex Pharmaceuticals (Ireland) Limited
- FinlandCasgevyVertex Pharmaceuticals (Ireland) Limited
- FranceCASGEVY 4 à 13 x 1 000 000 cellules/mL, dispersion pour perfusionVERTEX PHARMACEUTICALS (EUROPE) LIMITED
- United KingdomCasgevy 4million-13million cells/ml dispersion for infusion vialsVertex Pharmaceuticals (Europe) Ltd
- IrelandCasgevy 4 - 13 × 10^6 cells/mL dispersion for infusionVertex Pharmaceuticals (Ireland) Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Casgevy
- Liechtenstein · Casgevy
- Norway · Casgevy
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4887f2f6-f42d-4781-95d4-eba704e52a7c GET /v1/drugs/4887f2f6-f42d-4781-95d4-eba704e52a7c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "13000000",
"substance": "EXAGAMGLOGENE AUTOTEMCEL",
"productndc": "51167-290",
"dosage_form": "INJECTION, SUSPENSION",
"dea_schedule": null,
"strength_unit": "1/mL",
"application_number": "BLA125787",
"marketing_category": "BLA"
}See everything about exagamglogene autotemcel.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.